Navigation Links
Liver cells benefit from mesenchymal stem cell co-culture prior to transplantation
Date:12/18/2013

Putnam Valley, NY. (Dec. 18, 2013) Hepatocyte (liver cell) transplantation is becoming an accepted therapy for acute liver failure, either for liver regeneration or as a bridge to liver transplantation. However, maintaining the viability and functional aspects of hepatocytes has been a concern even with successful freezing (cryopreservation). In an effort to improve both the viability and function of cryopreserved hepatocytes prior to transplantation, researchers at Kings College Hospital, London, have co-cultured hepatocytes along with human mesenchymal stem cells (MSCs) derived from umbilical cord or fat tissues and found that the co-culturing confers improved hepatocyte survival and function.

The study will be published in a future issue of Cell Transplantation but is currently freely available on-line as an unedited early e-pub at: http://www.ingentaconnect.com/content/cog/ct/pre-prints/content-ct1038fitzpatrick.

The researchers hypothesized that when co-cultured with hepatocytes, MSCs - multipotent connective tissue cells that can differentiate into many kinds of cells - would lend pro-regenerative characteristics to hepatocytes.

"Both human umbilical cord and adipose tissue sources for MSCs were compared," said study corresponding author Dr. Emer Fitzpatrick of King's College Hospital. "Previous studies had used nonhuman cells with limited success. Human MSCs from both umbilical cords and adipose tissue have anti-apoptotic (anti-programmed cell death) and pro-regenerative effects on kidney failure and stroke and they are known to modulate liver injury and promote liver regeneration. While cryopreservation can have deleterious effects on hepatocyte cell engraftment, we wanted to investigate whether a co-culture of human MSCs and hepatocytes would improve hepatocyte function."

They found that MSCs and hepatocytes cul
'/>"/>

Contact: Robert Miranda
cogcomm@aol.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Page: 1 2

Related biology news :

1. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
2. Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins
3. Researchers unravel genetic mechanism of fatty liver disease in obese children
4. Commonly used diabetes drug may help to prevent primary liver cancer
5. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
6. Gut microbiota transplantation may prevent development of diabetes and fatty liver disease
7. Gallbladder shown as potential stem cell source for regenerative liver and metabolic disease
8. Family history of liver cancer increases risk of developing the disease
9. Modest alcohol intake associated with less inflammation in patients with common liver disease
10. Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial
11. Cancerous tumors deliver pro-metastatic information in secreted vesicles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... paving the way for a breakthrough that may ... exposed to poisonous chemicalsparticularly those in pesticides and ... current issue of the journal ChemBioChem ... compounds commonly used in pesticides and warfare agents. ... of Engineering Associate Professor of Chemical and Biological ...
(Date:7/30/2014)... studying the potential effects of climate change on ... on the wrong factors, according to a new ... Conservation Society, University of Queensland, and other organizations. ... science is missing the point when it comes ... of climate change scientists focus on the "direct" ...
(Date:7/30/2014)... pleased to announce its new relationship with the International ... CINP will partner to publish International Journal of ... journal. , Alan Frazer, Editor-in-Chief of IJNP ... of OUP will further facilitate the goal for the ... leading journals within neuropsychopharmacology. The conversion of the ...
Breaking Biology News(10 mins):Engineering a protein to prevent brain damage from toxic agents 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2OUP to partner with the International College of Neuropsychopharmacology 2
... a research team from the National Institute of Standards ... has shown how to detect and monitor the tiny ... of an atomic force microscope probe, and in so ... of the instruments measurements under ambient conditions. Their recently ...
... have learned to manipulate the proportion of females and ... mapped the entire genome of a bacterium that infects ... published in PNAS, reveal extremely high frequencies of gene ... it is hoped that it will be possible to ...
... DC, March 25, 2009 - Critically endangered hawksbill turtles ... the Dominican Republic after a powerful government campaign cracked ... 99 percent of these souvenirs have been withdrawn or ... A 2006 survey carried out by TRAFFIC found ...
Cached Biology News:Making a point: Picoscale stability in a room-temperature AFM 2Gene exchange common among sex-manipulating bacteria 2Turtles no longer turned into souvenirs 2
(Date:7/31/2014)... 2014 SoundConnect , an ... is proud to announce the addition of Adobe ... Connect’s elearning tools to quickly deploy and manage ... training tools for desktop and mobile learning solutions. ... the perfect online training solution, enabling organizations to ...
(Date:7/30/2014)... , July 30, 2014 Regulus ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 6, 2014, at 5:00 pm Eastern Daylight Time to ...
(Date:7/30/2014)... July 30, 2014 A study presented ... safety and efficacy of CSL Behring,s C1 Inhibitor ... transplants in highly sensitized patients. C1-INH is a ... complement system. The study shows that ... in the levels of complement components 3 and ...
(Date:7/30/2014)... 30, 2014 Selexis SA , ... drug discovery and mammalian cell line development, announced today ... ™ will be presented at the 10th Annual ... September 8 – 10, 2014 at the Double Tree ... The following abstract will be presented during an oral ...
Breaking Biology Technology:SoundConnect Enhances Portfolio with Adobe Connect Learning Management System (LMS) 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3
... County Representatives Unveil State-of-the-Art Facility ... ... Officials from Novavax,Inc. (Nasdaq: NVAX ), the State ... new state-of-the-art vaccine production,facility at the company,s headquarters in Rockville, ...
... Total Revenues of $62.0 Million, Up 55 Percent over First Quarter ... 2007, - First ... Before Non-Cash Charges of $1.13 per Basic Share, ... per Diluted Share, SILVER SPRING, Md., May 1 United Therapeutics,Corporation (Nasdaq: UTHR ) ...
... Strategic Transactions Increase EUSA,s Focus on Late-Stage and Marketed ... ... Products, DOYLESTOWN, Pennsylvania and OXFORD, England, May 1 ,EUSA ... pain control and critical care, today announced that,it has divested ...
Cached Biology Technology:Novavax Opens Its First U.S. Vaccine Plant 2Novavax Opens Its First U.S. Vaccine Plant 3Novavax Opens Its First U.S. Vaccine Plant 4United Therapeutics Reports First Quarter 2008 Financial Results 2United Therapeutics Reports First Quarter 2008 Financial Results 3United Therapeutics Reports First Quarter 2008 Financial Results 4United Therapeutics Reports First Quarter 2008 Financial Results 5United Therapeutics Reports First Quarter 2008 Financial Results 6United Therapeutics Reports First Quarter 2008 Financial Results 7EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 2EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 3
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient...
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient vir...
Src cDNA Expression Kit (wild type)...
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Biology Products: